mhurhangee/ep-ind-claims huggingface dataset:
A substrate/oriented apatite-type composite oxide film complex comprising an oriented apatite-type composite oxide film on a substrate, wherein a film thickness of the oriented apatite-type composite oxide film is 10.0 μm or less, a degree of orientation measured by the Lotgering method thereof is 0.6 or more, and a material of the substrate at a side on which at least the oriented apatite-type composite oxide film is formed is a metal, an alloy, a ceramic, or a composite material thereof. a film thickness of the oriented apatite-type composite oxide film is 10.0 μm or less, a degree of orientation measured by the Lotgering method thereof is 0.6 or more, and a material of the substrate at a side on which at least the oriented apatite-type composite oxide film is formed is a metal, an alloy, a ceramic, or a composite material thereof.
An automotive electronic control unit configured to sensorlessly control an automotive electrically-actuated device operated by a brushed DC electric motor and required to move from/to one or more end-of-travel positions; the electronic control unit is configured to detect reaching of an end-of-travel or stall position by the automotive electrically-actuated device based on: • an amplitude of an electric current absorbed by the automotive electrically-actuated device, and • a gradient of the amplitude of the electric current absorbed by the automotive electrically-actuated device; characterized in that the electronic control unit is further configured to detect reaching of an end-of-travel or stall position by the automotive electrically-actuated device also based on: • a ripple frequency of ripples in the amplitude of the electric current absorbed by the automotive electrically-actuated device and caused by the switching of the brushes of the DC electric motor. the electronic control unit is configured to detect reaching of an end-of-travel or stall position by the automotive electrically-actuated device based on: • an amplitude of an electric current absorbed by the automotive electrically-actuated device, and • a gradient of the amplitude of the electric current absorbed by the automotive electrically-actuated device; • an amplitude of an electric current absorbed by the automotive electrically-actuated device, and • a gradient of the amplitude of the electric current absorbed by the automotive electrically-actuated device; characterized in that the electronic control unit is further configured to detect reaching of an end-of-travel or stall position by the automotive electrically-actuated device also based on: • a ripple frequency of ripples in the amplitude of the electric current absorbed by the automotive electrically-actuated device and caused by the switching of the brushes of the DC electric motor. • a ripple frequency of ripples in the amplitude of the electric current absorbed by the automotive electrically-actuated device and caused by the switching of the brushes of the DC electric motor.
A device adapted for being implanted into a bronchus comprising: a hollow cylinder having two openings; wherein the hollow cylinder is shaped and extendible like an accordion, and characterised by a single valve in fluid connection with one of the openings, allowing fluid flow through the cylinder via the valve only, and wherein the device does not include a self-expanding scaffold located on the inner or outer wall of the hollow cylinder. a hollow cylinder having two openings; wherein the hollow cylinder is shaped and extendible like an accordion, and characterised by a single valve in fluid connection with one of the openings, allowing fluid flow through the cylinder via the valve only, and wherein the device does not include a self-expanding scaffold located on the inner or outer wall of the hollow cylinder.
DC high-voltage source for providing DC voltage, having: a capacitor stack - with a first electrode, which can be brought to a first potential, - with a second electrode, which is concentrically arranged with respect to the first electrode and can be brought to a second potential that differs from the first potential, - with at least one intermediate electrode, which is concentrically arranged between the first electrode and the second electrode and which can be brought to an intermediate potential situated between the first potential and the second potential, a switching device for charging the capacitor stack, to which the electrodes (33, 37, 39) of the capacitor stack are connected and which is embodied such that, during operation of the switching device, the electrodes (33, 37, 39) of the capacitor stack concentrically arranged with respect to one another can be brought to increasing potential levels, characterized in that the spacing of the electrodes (33, 37, 39) reduces toward the centre of the capacitor stack, wherein the switching device of the capacitor stack comprises electron tubes, more particularly controllable electron tubes. a capacitor stack - with a first electrode, which can be brought to a first potential, - with a second electrode, which is concentrically arranged with respect to the first electrode and can be brought to a second potential that differs from the first potential, - with at least one intermediate electrode, which is concentrically arranged between the first electrode and the second electrode and which can be brought to an intermediate potential situated between the first potential and the second potential, - with a first electrode, which can be brought to a first potential, - with a second electrode, which is concentrically arranged with respect to the first electrode and can be brought to a second potential that differs from the first potential, - with at least one intermediate electrode, which is concentrically arranged between the first electrode and the second electrode and which can be brought to an intermediate potential situated between the first potential and the second potential, a switching device for charging the capacitor stack, to which the electrodes (33, 37, 39) of the capacitor stack are connected and which is embodied such that, during operation of the switching device, the electrodes (33, 37, 39) of the capacitor stack concentrically arranged with respect to one another can be brought to increasing potential levels,
A communications product of a base station system, the communications product comprising a remote radio module and a mounting kit, wherein the mounting kit comprises a fastening part, the fastening part is configured to mount and fasten the remote radio module to a holder, the mounting kit further comprises a ventilation part and an air supply part, an air source is disposed inside the air supply part, the ventilation part is connected between the fastening part and the air supply part, a ventilation channel is disposed inside the ventilation part, and the ventilation channel allows the air supply part to communicate with the remote radio module, so that an air flow generated by the air source reaches the remote radio module after passing through the ventilation channel, to dissipate heat for the remote radio module, wherein the air supply part and the fastening part are located on two opposite sides of the ventilation part respectively, the three parts are arranged in a straight line, and the ventilation part is located right below or above the fastening part.
Underbody panelling for a motor vehicle, in particular a passenger car, with at least one underbody panelling element located in the region of a pivotable vehicle wheel and capable of moving together with a pivoting movement of the vehicle wheel, characterised in that at least one second underbody panelling element located in the region of the vehicle wheel and capable moving together with a pivoting movement of the vehicle wheel in a direction opposite to that of the first underbody panelling element is provided.
A method for transmitting a relay node, RN, specific physical downlink control channel, R-PDCCH, at a base station, eNB, in a Long Term Evolution, LTE, wireless communication system, the method comprising: mapping the R-PDCCH to resource elements, REs, by slot basis, wherein one or more aggregated Resource Blocks, RBs, consist of the REs, wherein the R-PDCCH is being mapped along a frequency direction in a symbol belonging to the lowest orthogonal frequency division multiplexing, OFDM, symbol index in a resource region allocated for an eNB-to-RN transmission over the aggregated RBs, and is then being mapped in the frequency direction in a symbol belonging to the next OFDM symbol index in the resource region allocated for the eNB-to-RN transmission over the aggregated RBs; and transmitting the R-PDCCH to an RN on the aggregated RBs via a downlink subframe configured for the eNB-to-RN transmission, and wherein the one or more RBs are aggregated based on a downlink bandwidth configuration and a size of a resource block group, RBG, which is the basic unit for resource allocation. mapping the R-PDCCH to resource elements, REs, by slot basis, wherein one or more aggregated Resource Blocks, RBs, consist of the REs, wherein the R-PDCCH is being mapped along a frequency direction in a symbol belonging to the lowest orthogonal frequency division multiplexing, OFDM, symbol index in a resource region allocated for an eNB-to-RN transmission over the aggregated RBs, and is then being mapped in the frequency direction in a symbol belonging to the next OFDM symbol index in the resource region allocated for the eNB-to-RN transmission over the aggregated RBs; and transmitting the R-PDCCH to an RN on the aggregated RBs via a downlink subframe configured for the eNB-to-RN transmission, and wherein the one or more RBs are aggregated based on a downlink bandwidth configuration and a size of a resource block group, RBG, which is the basic unit for resource allocation.
A (i) first population of modified human T cells and (ii) a second population of modified T cells for use in a method for treating a cancer, comprising: (a) administering to a subject an effective amount of the first population of modified human T cells of (i) comprising an exogenous nucleic acid molecule that encodes a chimeric antigen receptor that specifically binds to a tumor cell-surface antigen associated with the cancer, wherein the CAR comprises a hydrophobic portion disposed between an extracellular binding component and an intracellular effector component, wherein the intracellular effector component comprises an intracellular region of CD3ζ and CD27, CD3ζ and CD28, CD3ζ and CD134, or CD3ζ and CD137, and wherein the modified human T cells express the CAR; (b) administering to the subject an effective amount of the second population of modified T cells of (ii) comprising an exogenous nucleic acid molecule that encodes the tumor cell-surface antigen, wherein the extracellular binding component of the CAR from the modified human T cells of step (a) is specific for the antigen encoded by the population of modified T cells of this step (b), wherein the modified T cells of this step (b) express the tumor cell-surface antigen; and (c) optionally repeating step (a), step (b) or both steps (a) and (b); thereby treating the cancer by adoptive cellular immunotherapy or treating the cancer. (a) administering to a subject an effective amount of the first population of modified human T cells of (i) comprising an exogenous nucleic acid molecule that encodes a chimeric antigen receptor that specifically binds to a tumor cell-surface antigen associated with the cancer, wherein the CAR comprises a hydrophobic portion disposed between an extracellular binding component and an intracellular effector component, wherein the intracellular effector component comprises an intracellular region of CD3ζ and CD27, CD3ζ and CD28, CD3ζ and CD134, or CD3ζ and CD137, and wherein the modified human T cells express the CAR; (b) administering to the subject an effective amount of the second population of modified T cells of (ii) comprising an exogenous nucleic acid molecule that encodes the tumor cell-surface antigen, wherein the extracellular binding component of the CAR from the modified human T cells of step (a) is specific for the antigen encoded by the population of modified T cells of this step (b), wherein the modified T cells of this step (b) express the tumor cell-surface antigen; and (c) optionally repeating step (a), step (b) or both steps (a) and (b);
A method for treating biomass composed of integrated feedstocks to produce fermentable sugars, and using said fermentable sugars to produce a target chemical, said method comprising: a) providing biomass; b) adding to the biomass of (a) at least one alternative feedstream to produce an integrated feedstock; c) contacting the integrated feedstock of (b) with an aqueous solution comprising ammonia to form an integrated feedstock-aqueous ammonia mixture, wherein the ammonia is present at a concentration at least sufficient to maintain alkaline pH of the integrated feedstock-aqueous ammonia mixture but wherein said ammonia is present at less than 12 weight percent relative to dry weight of integrated feedstock, and further wherein the dry weight of integrated feedstock is at a high solids concentration of at least 15 weight percent relative to the weight of the integrated feedstock-aqueous ammonia mixture, to produce a pretreated integrated feedstock product; d) contacting the product of (c) with a saccharification enzyme consortium comprising a cellulose-hydrolyzing glycosidase and a hemicellulose-hydrolyzing glycosidase under suitable conditions to produce a fermentable sugar product; and e) fermenting the fermentable sugars produced in step (d) using a suitable microorganism to produce the target chemical. a) providing biomass; b) adding to the biomass of (a) at least one alternative feedstream to produce an integrated feedstock; c) contacting the integrated feedstock of (b) with an aqueous solution comprising ammonia to form an integrated feedstock-aqueous ammonia mixture, wherein the ammonia is present at a concentration at least sufficient to maintain alkaline pH of the integrated feedstock-aqueous ammonia mixture but wherein said ammonia is present at less than 12 weight percent relative to dry weight of integrated feedstock, and further wherein the dry weight of integrated feedstock is at a high solids concentration of at least 15 weight percent relative to the weight of the integrated feedstock-aqueous ammonia mixture, to produce a pretreated integrated feedstock product; d) contacting the product of (c) with a saccharification enzyme consortium comprising a cellulose-hydrolyzing glycosidase and a hemicellulose-hydrolyzing glycosidase under suitable conditions to produce a fermentable sugar product; and e) fermenting the fermentable sugars produced in step (d) using a suitable microorganism to produce the target chemical.
A service bearing method, for bearing a service in multicast broadcast single frequency network, MBSFN, subframes, characterized by comprising: a network side converting MBSFN subframe which does not bear a MBMS service to a unicast subframe; and bearing a unicast service on the converted unicast subframe; wherein the step of converting the MBSFN subframe to the unicast subframe comprises: converting a non-MBSFN region of the MBSFN subframe to a control region of the unicast subframe; wherein after converting the MBSFN subframe to the unicast subframe, the method further comprises: indicating downlink resource assignment information of the unicast service in the control region of the unicast subframe. a network side converting MBSFN subframe which does not bear a MBMS service to a unicast subframe; and bearing a unicast service on the converted unicast subframe; wherein the step of converting the MBSFN subframe to the unicast subframe comprises: converting a non-MBSFN region of the MBSFN subframe to a control region of the unicast subframe; wherein after converting the MBSFN subframe to the unicast subframe, the method further comprises: indicating downlink resource assignment information of the unicast service in the control region of the unicast subframe.
An electret web comprising: a thermoplastic resin; and a charge-enhancing additive comprising at least one substituted benzotriazole phenolate salt. a thermoplastic resin; and a charge-enhancing additive comprising at least one substituted benzotriazole phenolate salt.
A syringe pump including infusion means including a mounting portion (2b, 2c, 5) which fixes a syringe main body filled with a medicinal solution to a device main body and a slider assembly which drives a syringe plunger in an infusing direction after the syringe plunger is mounted, occlusion detection means for detecting an occluded state in an infusion line to which the syringe main body is connected, by detecting an internal syringe pressure at the time of infusion, occlusion setting display means including an occlusion setting unit which arbitrarily sets a degree of occlusion of the occluded state and a first occlusion display unit which displays when the occluded state exceeds the degree of occlusion, and a main control means, wherein the syringe pump is characterized in that the main control means includes occlusion management means including a storage unit which stores the internal syringe pressures at predetermined intervals of seconds from the start of infusion, the syringe pump includes a second occlusion display unit which displays the stored internal syringe pressures at predetermined intervals of minutes in chronological order as a degree of occlusion, and the occlusion management means includes a table storing occlusion pressures of a normal internal syringe pressure in association with at least one of a syringe type, a syringe volume, a syringe diameter and a manufacturer thereof, wherein, when the occlusion management means determines based on the stored internal syringe pressures and the table that the internal syringe pressure tends to exceed the normal internal syringe pressure, the occlusion management means causes the second occlusion display unit to display character information indicating rise in occlusion pressure in highlight, and to also make a backlight blink to display a warning. infusion means including a mounting portion (2b, 2c, 5) which fixes a syringe main body filled with a medicinal solution to a device main body and a slider assembly which drives a syringe plunger in an infusing direction after the syringe plunger is mounted, occlusion detection means for detecting an occluded state in an infusion line to which the syringe main body is connected, by detecting an internal syringe pressure at the time of infusion, occlusion setting display means including an occlusion setting unit which arbitrarily sets a degree of occlusion of the occluded state and a first occlusion display unit which displays when the occluded state exceeds the degree of occlusion, and a main control means,
Awning device (1, 20, 40), comprising an awning with at least one arch element stabilizing an arch, at least one winding shaft for winding up and off the awning, and at least one traction rope, wherein the at least one traction rope is connected with a first region of the awning which, in the wound off state of the awning, is tightly tensioned and within which a section of the at least one arch element is arranged, wherein the at least one arch element is, in the non-loaded state, essentially straight or comprises, at least in one section, an arch facing to the bottom, characterized in that the awning comprises, at least on one side of the first region, a second region into which the at least one arch element extends, the second region being mounted on the at least one arch element in a loosely hanging manner.
A vane for a gas turbine engine, the vane comprising a three-dimensional weave of composite material, wherein the vane is hollow to define a hollow core, and wherein the vane has a maximum thickness, and a maximum wall thickness between an inner surface and an outer surface in a direction normal to the outer surface (W T), characterized in that, W T ≤0.1T and ≥0.05T.
A process for the purification of L-α-glycerophosphorylcholine, characterized in that L-α-glycerophosphorylcholine is crystallized from DMSO or a mixture of DMSO with at least another solvent and characterized in that DMSO is used in an amount comprised between 2 and 100 parts by volume per part by weight of L-α-glycerophosphorylcholine.
A method of positioning a monument within an aircraft having a floor that includes a plurality of connection points, the method comprising the steps of: (a) positioning at least first and second tracks on the aircraft floor, wherein the first and second tracks have a forward end and an aft end, wherein the first track includes at least a first carriage thereon that is movable longitudinally therealong, wherein the second track includes at least a second carriage thereon that is movable longitudinally therealong, wherein the first and second carriages are initially in a first position, (b)positioning a floor of a first monument section on the first carriage, wherein the floor includes at least a first fitting having an opening therein, (c) positioning a floor of a second monument section on the carriage of the second track, wherein the floor includes at least a second fitting having an opening therein, (d) moving the first and second monument sections together with the carriages, whereby the carriages move along the first and second tracks from the first position to a second position, (e) aligning the first fittings with a connection point on the aircraft floor, (f) raising the floor of the first monument section and removing the first track, (g) raising the floor of the second monument section and removing the second track, (h) lowering the floor of the first monument section, (i) lowering the floor of the second monument section, (j) securing the first fitting to the connection point associated therewith, and (k) securing the second fitting to the connection point associated therewith. (a) positioning at least first and second tracks on the aircraft floor, wherein the first and second tracks have a forward end and an aft end, wherein the first track includes at least a first carriage thereon that is movable longitudinally therealong, wherein the second track includes at least a second carriage thereon that is movable longitudinally therealong, wherein the first and second carriages are initially in a first position, (b)positioning a floor of a first monument section on the first carriage, wherein the floor includes at least a first fitting having an opening therein, (c) positioning a floor of a second monument section on the carriage of the second track, wherein the floor includes at least a second fitting having an opening therein, (d) moving the first and second monument sections together with the carriages, whereby the carriages move along the first and second tracks from the first position to a second position, (e) aligning the first fittings with a connection point on the aircraft floor, (f) raising the floor of the first monument section and removing the first track, (g) raising the floor of the second monument section and removing the second track, (h) lowering the floor of the first monument section, (i) lowering the floor of the second monument section, (j) securing the first fitting to the connection point associated therewith, and (k) securing the second fitting to the connection point associated therewith.